Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Chronic Cough and Reflux Disease
NCT00287339Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic cough and gastroesophageal reflux disease (GERD) comparing Esomeprazole Arm with Placebo Arm (2 arms). Primary endpoint: Cough-Specific Quality of Life Questionnaire at 12 weeks. Started Sep 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
chronic coughgastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00287339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287339.